Andreas Lutterotti

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis

Ivan Jelčić, Faiez Al Nimer, Jian Wang et al. · Cell · 2018 · 519 citations · Full text

Life Sciences, Immunology, Neurology +17

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

Simone Mader, Viktoria Gredler, Kathrin Schanda et al. · Journal of Neuroinflammation · 2011 · 444 citations · Full text

Life Sciences, Neurology, Neuroscience +17

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2

Jan D. Lünemann, Ilijas Jelčić, Susanne Roberts et al. · The Journal of Experimental Medicine · 2008 · 326 citations · Full text

Life Sciences, Immunology, Neurology +17

Antigen-Specific Tolerance by Autologous Myelin Peptide–Coupled Cells: A Phase 1 Trial in Multiple Sclerosis

Andreas Lutterotti, Sara Yousef, Andreas Sputtek et al. · Science Translational Medicine · 2013 · 279 citations

Life Sciences, Immunology, Neurology +17